How Eno was paid
$1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Robert EnoChief Executive Officer (Former President) | $360,000 | $128,520 | $39,999 | $451,694 | $1,028 | $1,036,321 |
| Branislav Vajdic, PhDPresident (Former Chief Executive Officer) | $404,100 | $144,264 | — | $330,876 | $4,944 | $946,011 |
| Kenneth PersenChief System Deployment Officer | $312,000 | $58,477 | — | $28,231 | $3,048 | $426,817 |
| Timothy CruickshankChief Financial Officer | $346,500 | $92,775 | $38,499 | $211,732 | — | $729,505 |
What changed and why
- $1.04M$1.04 million was Robert Eno’s 2025 total compensation, versus $490,675 in 2024.
- 20%20% salary reductions for six months were offset with equity grants under the 2025 Equity Compensation Program.
- $55,080$55,080 of Eno’s 2025 compensation was an equity bonus in lieu of cash.
- $61,827$61,827 of Vajdic’s 2025 compensation was an equity bonus in lieu of cash.
- 60%60% of certain option awards vest upon FDA clearance for the synthesized 12L product.
- 2025 bonuses were awarded partly in cash and partly as equity-in-lieu-of-cash, with cash payments expected in early 2026.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.